Physician

Shailendra Sharma, M.D

According to 2025 Medicare claims, Shailendra Sharma, M.D (NPI: 1700063575) practices internal medicine in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is EDWARD W SPARROW HOSPITAL ASSOCIATION (NPI: 1568867190; TIN: 381360584) and primary practice location at 48912-1811. Sharma is affiliated with the PBACO Holding, LLC (ACO ID: A1001), POM ACO (ACO ID: A1297), and Aledade 201 National MSSP (ACO ID: A5522), participating under the MSSP model.

Sharma's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 323 traditional Medicare patients, billed 1,107 HCPCS/CPT codes, and received $128,921 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 1,142 prescription claims across 258 beneficiaries totaling $197,320 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 41 claims. Open Payments data shows 55 records totaling $1,208. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $73,431 to $128,921. Similarly, Part D prescription costs have risen steadily, from $643 to $197,320. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	249	1,007	$73,431
2016	268	1,510	$102,880
2017	344	1,681	$130,726
2018	332	1,678	$110,604
2019	354	1,512	$108,670
2020	396	1,323	$105,823
2021	422	1,655	$167,308
2022	360	1,580	$190,587
2023	336	1,225	$142,678
2024	323	1,107	$128,921

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	24	$643
2016	36	162	$8,569
2017	43	224	$15,033
2018	38	199	$9,961
2019	41	180	$9,722
2020	83	213	$10,577
2021	176	570	$56,920
2022	171	482	$70,035
2023	218	794	$211,541
2024	258	1,142	$197,320

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	36	$595
2024	N/R	41	$616

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	81	196	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	73	110	$72
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	79	161	$58
90935	Hemodialysis procedure with physician evaluation	63	129	$52
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	53	62	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	32	1,960	$34,027
Jardiance	Empagliflozin	27	1,865	$33,557
Velphoro	Sucroferric Oxyhydroxide	12	360	$26,615
Procrit	Epoetin Alfa	21	702	$12,310
Sevelamer Carbonate	Sevelamer Carbonate	30	1,820	$7,607

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	14	$239
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	13	$213
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	14	$164

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$1,208	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shailendra Sharma, M.D?

Tedicare shows public-source Medicare data for Shailendra Sharma, M.D (NPI 1700063575), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shailendra Sharma, M.D have ACO affiliation data?

Shailendra Sharma, M.D is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001), POM ACO (MSSP, ACO ID A1297), and Aledade 201 National MSSP (MSSP, ACO ID A5522).

What billing organization is linked to Shailendra Sharma, M.D?

Shailendra Sharma, M.D is linked to EDWARD W SPARROW HOSPITAL ASSOCIATION (billing NPI 1568867190) in the available physician profile data.

Does Shailendra Sharma, M.D have Open Payments data?

Shailendra Sharma, M.D has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.